The dishonest mainstream media and their overlords in the Democrat Party have been manipulating the truth about the CCP virus almost since it entered the United States.
Billions of dollars have been being given to pharmaceutical companies, hospitals, health care providers, and even funeral directors who indirectly benefit from money given to qualified family members courtesy of FEMA if “COVID19” is the stated reason for the death of their loved ones on the death certificate.
Is it any wonder that Americans are confused about masks or how safe or effective COVID vaccines are–especially considering how many Democrat leaders said they wouldn’t get the vaccine after President Trump announced the record-breaking release of the COVID shots before the November 2020 election?
When Americans weren’t rushing to get the vaccine, the liberal media was quick to insinuate that “Trump supporters,” or less-educated, stupid white people were the problem. But, according to a paper by researchers from Carnegie Mellon University and the University of Pittsburgh, Americans with PhDs are the most hesitant when it comes to getting the COVID jab. According to the survey, they are also the least likely to change their minds about getting the shot.
Daily Mail reports – Researchers surveyed just over five million US adults in an online survey, with 10,000 reporting that they received Ph.Ds.
The other least likely group to be vaccinated are Blacks and Hispanics – and people with a high school education or less.
The data was published as a pre-print on medRxiv.org and has not been peer-reviewed. It will need to be reviewed before it can be published in an accredited journal.
Many Americans who are hesitant about getting the vaccine have cited the lack of approval for the COVID jab by the Food and Drug Administration as a reason, pointing out that the jab has only been given FDA approval for Emergency Use Authorization.
Now, according to the Daily Mail, The New York Times is reporting the U.S. Food and Drug Administration (FDA) plans on giving full approval to the Pfizer-BioNTech COVID-19 vaccine by Monday.
The two-dose vaccine was the first to receive emergency use authorization in December 2020.
Sources told The Times that the FDA had previously expected to approve the vaccine before Labor Day but decided to expedite the timeline.
Regulators are currently working through paperwork, and final negotiations with the company before the Pfizer vaccine becomes the first to receive full authorization.
Full approval by the FDA could push more Americans to get the COVID-19 vaccine as it might reduce their fears about the safety of the shot.
